Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, continues to be a significant global health concern. This article presents an updated approach to its diagnosis and treatment, providing a comprehensive guide for healthcare professionals.
The gold standard for diagnosing enteric fever remains blood culture, despite its limitations in sensitivity. Molecular methods, such as Polymerase Chain Reaction (PCR), are emerging as promising tools due to their high sensitivity and specificity. However, these require specialized facilities and trained personnel. Serological tests, like the Widal test, can be useful in resource-limited settings, but their reliability is often questioned due to cross-reactivity.
Antibiotic therapy is the mainstay of treatment for enteric fever. Choice of antibiotic should be guided by local antimicrobial resistance patterns. Fluoroquinolones were once the first-line treatment but rising resistance has necessitated a shift towards third-generation cephalosporins and azithromycin. The role of vaccines in prevention should not be underestimated, especially in endemic areas.
Public health interventions play a crucial role in controlling enteric fever. These include access to clean water, improved sanitation, and food safety measures. In addition, surveillance systems can help monitor disease trends and antimicrobial resistance, guiding policy and practice.
Enteric fever remains a significant public health challenge requiring a multi-faceted approach. While diagnostic methods and treatment strategies continue to evolve, the importance of public health measures in disease control cannot be overstated. As healthcare professionals, staying abreast of these updates is crucial in delivering effective patient care and contributing to global health improvement.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation